Daniel MacArthur

@dgmacarthur

Human genomics, rare disease, and open data. Co-director of Medical and Population Genetics at .

Boston, USA
Дата регистрации: октябрь 2008 г.

Твиты

Вы внесли @dgmacarthur в черный список

Вы уверены, что хотите видеть эти твиты? Если вы просто просмотрите твиты, @dgmacarthur по-прежнему останется в черном списке.

  1. Закрепленный твит
    17 окт.

    KK: The new data set is live, with an awesome new browser! Thanks to the tireless work of our engineering team, Nick Watts and , working right up to about 3 minutes before this talk (DM: can confirm.).

    Отменить
  2. ретвитнул(а)
    16 часов назад

    Australia cuts research funding for universities. Funding for research and development is at its lowest point in 40 years—even as Australia forecasts a budget surplus of AU$4.1 billion in 2019-2020

    Отменить
  3. ретвитнул(а)
    22 часа назад

    At 23andMe, taking calls from people who just got a life-changing surprise is so stressful that customer service reps are encouraged to go for a walk after an intense call, or crack open a bottle of wine. Great story via

    Отменить
  4. ретвитнул(а)
    23 часа назад

    If you’re writing about data-sharing and your article is behind a paywall with no preprint on biorxiv, it’s perhaps time to revisit your definitions of both “data” and “sharing” 🧐

    Отменить
  5. ретвитнул(а)
    18 дек.

    1. What is the probability that the mutations carried by CRIPR twins Lulu and Nana are already present in the human population?

    Показать эту ветку
    Отменить
  6. ретвитнул(а)
    15 дек.
    В ответ и еще

    And without further ado, here's "A simple new approach to variable selection in regression, with application to genetic fine mapping" by

    Отменить
  7. ретвитнул(а)
    24 часа назад

    How you make 2,300 attendees at the Broad Retreat feel like they belong

    Отменить
  8. ретвитнул(а)
    17 дек.

    We interviewed Mark Daly , newly appointed Director of for our website, as part of our 'Welcome to' series. Here, Prof. Daly discusses his into human , and why he chose to swap the USA for Finland:

    Отменить
  9. ретвитнул(а)
    18 дек.

    If you're not a fan of extreme p-values in you can stop reading right here. But since I've been following the Manhattan plots generated by from the group I thought I'd "skip to the end" and look up most extreme p-value for any trait/any SNP 👇

    Показать эту ветку
    Отменить
  10. ретвитнул(а)
    16 дек.

    WRITING A PAPER IN WORD: FONT TIPS Contrary to widely held belief (among LaTeX fands), it is easy to write a nice-looking paper in Word. You just have to do three things: (1) use styles; (2) avoid hideous fonts; (3) unleash the fonts’ potential. 2\

    Показать эту ветку
    Отменить
  11. ретвитнул(а)
    18 дек.

    We are looking for two 's to join our team at in Helsinki! We offer a great opportunity to work in the forefront of the new wave of big data application for genome health. Read more and apply by 31 Jan!

    Отменить
  12. ретвитнул(а)
    18 дек.

    `the GDPR has had the unintended (but wholly predictable) consequence of consolidating market power behind the mega firms that privacy advocates hoped to take down. There is a reason that the GDPR earned its informal nickname of the "Google Data Protection Regulation"`

    Отменить
  13. 17 дек.

    Where to go for rare disease diagnoses after exome sequencing fails? Excellent review of the options by and :

    Отменить
  14. ретвитнул(а)
    17 дек.

    Check out the omission of proper negative controls.

    Отменить
  15. ретвитнул(а)
    16 дек.

    Your regular friendly reminder that vaccines are completely, utterly, totally, and entirely unrelated to the development of autism (N = 1.3 million)

    Отменить
  16. ретвитнул(а)
    16 дек.

    A Powerful Lesson That Patients Deserve Full Control Of Their Genetic Data: 🧬A lab can refuse to share data to protect their own market position 🧬At the expense of scientific progress, and the very patients who paid them to conduct genetic testing 👉

    Отменить
  17. ретвитнул(а)
    16 дек.

    folks, we need to demand high standards in the current gold rush of methods devel. It's not OK for methods to be published w/ vaporware implementations. We need open src code written in open src languages w/ documentation, test data, unit tests, pkg'd, installable.

    Показать эту ветку
    Отменить
  18. ретвитнул(а)
    16 дек.

    As a Pfizer scientist I work alongside talented immigrants from all over the world. - why are you advertising on Tucker Carlson? Do you support his views on immigrants? What message are you sending to our colleagues and customers?

    Отменить
  19. ретвитнул(а)
    16 дек.

    New: "p-Hacking & False Discovery in A/B Testing" Setup: 2,101 RCTs in which businesses track effects over time. "73% of experimenters stop experiment[s] when a[n] effect reaches 90% confidence...75% of the effects are truly null."

    Показать эту ветку
    Отменить
  20. ретвитнул(а)
    14 дек.

    Reference genome falls down again; Southern blots are sometimes a geneticists best friend (especially in repeat regions). Lessons to live by, that I have encountered now in three separate phases of my career, summed up in a beautiful paper by and colleagues!

    Отменить
  21. ретвитнул(а)
    15 дек.

    UCLA asked faculty to consider declining to review for Elsevier journals

    Показать эту ветку
    Отменить

Загрузка может занять некоторое время.

Вероятно, серверы Твиттера перегружены или в их работе произошел кратковременный сбой. Повторите попытку или посетите страницу Статус Твиттера, чтобы узнать более подробную информацию.

    Вам также может понравиться

    ·